The commentary is not meant to diagnose, treat or replace conventional treatment, and has not been approved or reviewed by the FDA, Health Canada, BMS, European Union Health Commission, South and Central American regulation agencies etc.
These mechanisms together allow for significant blood glucose control and meaningful weight loss
Central appetite suppression: Amylin crosses blood-brain barrier Activates area postrema (brainstem) Also acts on nucleus accumbens Direct satiety signaling Reduces desire to eat Different brain pathways than GLP-1 3
Some good may come of it, and even if patients are given a therapeutic trial of B12 injections it would be interested to see if they improved
doi: 10.1038/s41598-024-81845-6 60
Medical disclaimer: Lab testing supports informed decisions but does not diagnose every medication complication or replace professional medical care